As I said back in October, delivering a successful Covid-19 vaccine quickly was a huge challenge, but the diversity of the UK’s vaccine portfolio and the amendments made to the Human Medicines Regulations 2012 (HMRs) meant...more
The UK’s vaccine portfolio The UK Government has agreed supply deals for at least 340 million doses of six different vaccines, with most likely to require two doses: The vaccines are based on a range of vaccine technologies...more
11/5/2020
/ AstraZeneca ,
Biotechnology ,
Coronavirus/COVID-19 ,
GlaxoSmithKline ,
Infectious Diseases ,
Johnson & Johnson ,
Life Sciences ,
Pfizer ,
Public Health Emergency ,
Research and Development ,
Sanofi ,
UK ,
Vaccinations